Clinical Trial Update: A Study of GNTI-122 in Adults Recently Diagnosed With T1D [Phase 1]

View source ↗

Summary

This document notes an ongoing Phase 1 trial of GNTI-122 in adults recently diagnosed with Type 1 diabetes mellitus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GNTI-122

Snippet

Sponsor: GentiBio, Inc | Conditions: Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus | Phase 1 | Status: RECRUITING